Nivolumab vs Omeprazole
Nivolumab vs Omeprazole: Overview
This comparison examines the pharmacological differences between Nivolumab and Omeprazole.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Omeprazole: Proton pump inhibitor that irreversibly blocks H+/K+-ATPase.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Omeprazole — 0.5-1 hour.
Chemical Properties
Molecular Formula: Omeprazole — C17H19N3O3S.
Molecular Weight: Omeprazole — 345.4170 g/mol.
Type: Nivolumab — Antibody; Omeprazole — Small molecule.